Debt-to-equity of TFF Pharmaceuticals, Inc. from 30 Jun 2020 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TFF Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2020 to 30 Sep 2024.
  • TFF Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2024 was 58%, a 606% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

TFF Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2024 58% +50% +606% 30 Sep 2024
Q2 2024 32% +23% +253% 30 Jun 2024
Q1 2024 22% +10% +93% 31 Mar 2024
Q4 2023 13% +2.7% +27% 31 Dec 2023
Q3 2023 8.2% -0.96% -10% 30 Sep 2023
Q2 2023 9.2% +2.4% +35% 30 Jun 2023
Q1 2023 11% +7% +167% 31 Mar 2023
Q4 2022 10% +6.6% +193% 31 Dec 2022
Q3 2022 9.2% +6.1% +196% 30 Sep 2022
Q2 2022 6.8% +3.6% +112% 30 Jun 2022
Q1 2022 4.2% +0.8% +24% 31 Mar 2022
Q4 2021 3.4% -0.39% -10% 31 Dec 2021
Q3 2021 3.1% -1.2% -28% 30 Sep 2021
Q2 2021 3.2% -5.6% -63% 30 Jun 2021
Q1 2021 3.4% 31 Mar 2021
Q4 2020 3.8% 31 Dec 2020
Q3 2020 4.3% 30 Sep 2020
Q2 2020 8.8% 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.